Qifu F. Li

Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 201 publications

Primary Aldosteronism Medical Treatment Outcomes (PAMO) Beyond 12 Months.

Primary Aldosteronism Medical Treatment Outcomes (PAMO) Beyond 12 Months.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: July 22, 2026

Interpretation of the Expert Consensus on Subtyping Diagnosis of Primary Aldosteronism (2026): Chinese evidence, Chinese strategies

Interpretation of the Expert Consensus on Subtyping Diagnosis of Primary Aldosteronism (2026): Chinese evidence, Chinese strategies

Journal: Zhonghua nei ke za zhi

Published: July 10, 2026

Re-validation of the prediction model for unilateral primary aldosteronism

Re-validation of the prediction model for unilateral primary aldosteronism

Journal: Zhonghua nei ke za zhi

Published: July 10, 2026

Advances in the application of nanoparticles for the diagnosis and treatment of diabetic cardiomyopathy.

Advances in the application of nanoparticles for the diagnosis and treatment of diabetic cardiomyopathy.

Journal: Frontiers in cell and developmental biology

Published: June 18, 2026

Endoscopic ultrasound-guided ethanol ablation for aldosterone-producing adenoma.

Endoscopic ultrasound-guided ethanol ablation for aldosterone-producing adenoma.

Journal: Endoscopy

Published: June 11, 2026

Long-Term Mortality in Diabetic Foot Disease is Higher Than That of Overall Cancer: Results From Three International Cohorts.

Long-Term Mortality in Diabetic Foot Disease is Higher Than That of Overall Cancer: Results From Three International Cohorts.

Journal: Diabetes/metabolism research and reviews

Published: May 25, 2026

KCNJ5-Dependent 68Ga-Pentixafor PET/CT in Primary Aldosteronism Surgery.

KCNJ5-Dependent 68Ga-Pentixafor PET/CT in Primary Aldosteronism Surgery.

Journal: The Journal of clinical endocrinology and metabolism

Published: May 07, 2026

New insights in primary aldosteronism diagnosis: a prospective multicenter study.

New insights in primary aldosteronism diagnosis: a prospective multicenter study.

Journal: Clinical chemistry and laboratory medicine

Published: April 14, 2026

Maresin-1 ameliorates renal oxidative stress and inflammation in diabetic kidney disease mice partially dependent on apolipoprotein D upregulation.

Maresin-1 ameliorates renal oxidative stress and inflammation in diabetic kidney disease mice partially dependent on apolipoprotein D upregulation.

Journal: Cellular signalling

Published: March 16, 2026

Association of BMI Change with New-Onset or Progressive Diabetic Kidney Disease in People with Normal-Weight Type 2 Diabetes.

Association of BMI Change with New-Onset or Progressive Diabetic Kidney Disease in People with Normal-Weight Type 2 Diabetes.

Journal: Journal of clinical medicine

Published: February 28, 2026

Efficacy and safety of HRS-7535, an oral small-molecule GLP-1 receptor agonist, in patients with diabetic kidney disease (SOLID-DKD): a randomised, double-blind, placebo-controlled, phase 2 trial.

Efficacy and safety of HRS-7535, an oral small-molecule GLP-1 receptor agonist, in patients with diabetic kidney disease (SOLID-DKD): a randomised, double-blind, placebo-controlled, phase 2 trial.

Journal: EClinicalMedicine

Published: February 23, 2026

Establishing LC-MS/MS-based cutoffs for the confirmatory testing for primary aldosteronism: a prospective multi-center study

Establishing LC-MS/MS-based cutoffs for the confirmatory testing for primary aldosteronism: a prospective multi-center study

Journal: Zhonghua nei ke za zhi

Published: February 03, 2026

Showing 1-12 of 201

Last Updated: 09/26/2026